International perspective on health-related quality-of-life research in cancer clinical trials: the European Organisation for Research and Treatment of Cancer experience
about
Recommended patient-reported core set of symptoms to measure in adult cancer treatment trialsQuality of Life Measurements: Any Value for Clinical Practice?Group medical visits in the follow-up of women with a BRCA mutation: design of a randomized controlled trial.Examining the relationships among health-related quality-of-life indicators in cancer patients participating in clinical trials: a pooled study of baseline EORTC QLQ-C30 data.Towards the Implementation of Quality of Life Monitoring in Daily Clinical Routine: Methodological Issues and Clinical Implication.When using patient-reported outcomes in clinical practice, the measure matters: a randomized controlled trialDecreased health-related quality of life in disease-free survivors of differentiated thyroid cancer in Korea.DNA-testing for BRCA1/2 prior to genetic counselling in patients with breast cancer: design of an intervention study, DNA-direct.Current and recent clinical trials for perioperative systemic therapy for muscle invasive bladder cancer: a systematic review.Health-related quality of life after cystectomy and urinary diversion for bladder cancer.Beyond drug use: a systematic consideration of other outcomes in evaluations of treatments for substance use disorders.Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial.High Satisfaction and Low Distress in Breast Cancer Patients One Year after BRCA-Mutation Testing without Prior Face-to-Face Genetic CounselingResponsiveness of the EQ-5D in breast cancer patients in their first year after treatmentMeasuring outcomes in oncology treatment: the importance of patient-centered outcomesAdded value of health-related quality of life measurement in cancer clinical trials: the experience of the NCIC CTG.Systematic review reveals limitations of studies evaluating health-related quality of life after potentially curative treatment for esophageal cancer.A novel systemic immune-inflammation index predicts survival and quality of life of patients after curative resection for esophageal squamous cell carcinoma.A large scale prospective clinical and psychometric validation of the EORTC colorectal (QLQ-CR29) module in Polish patients with colorectal cancer.Group medical consultations in the follow-up of breast cancer: a randomized feasibility study.Transdermal buprenorphine for the treatment of cancer pain: results from a multicenter, observational, post-marketing study in Spain (RELIEF study).More breast cancer patients prefer BRCA-mutation testing without prior face-to-face genetic counseling.Health-related quality-of-life results from PALETTE: A randomized, double-blind, phase 3 trial of pazopanib versus placebo in patients with soft tissue sarcoma whose disease has progressed during or after prior chemotherapy-a European Organization fHealth-related quality of life with adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): secondary outcomes of a multinational, randomised, double-blind, phase 3 trial.Patient experiences with gene panels based on exome sequencing in clinical diagnostics: high acceptance and low distress.Validation of the Polish version of the EORTC QLQ-BM22 module for the assessment of health-related quality of life in patients with bone metastases.Association of health-related quality of life with gender in patients with B-cell chronic lymphocytic leukemia.A systematic review and development of a classification framework for factors associated with missing patient-reported outcome data.Assessment of quality of life in advanced, metastatic prostate cancer: an overview of randomized phase III trials.Can we test for hereditary cancer at 18 years when we start surveillance at 25? Patient reported outcomes.Validation of the Polish version of the EORTC QLQ-OV28 module for the assessment of health-related quality of life in women with ovarian cancer.Testing the measurement equivalence of paper and interactive voice response system versions of the EORTC QLQ-C30.Validation of the Polish version of the EORTC QLQ-CX24 module for the assessment of health-related quality of life in women with cervical cancer.High level of distress in long-term survivors of thyroid carcinoma: results of rapid screening using the distress thermometer.Mapping the cancer-specific EORTC QLQ-C30 and EORTC QLQ-BR23 to the generic EQ-5D in metastatic breast cancer patients.Enhancing patient-reported outcome measurement in research and practice of palliative and end-of-life care.Danish translation and pilot testing of the European Organization for Research and Treatment of Cancer QLQ-TC 26 (EORTC QLQ-TC26) questionnaire to assess health-related quality of life in patients with testicular cancer.
P2860
Q28655361-724E68AF-C3B5-4E78-99E2-C6FD4B80DAC1Q30234561-B6C7CFFC-F8E9-4867-8880-F4BB3F1B8034Q34001845-324E8231-0092-43D9-A385-2E6B4F5A6544Q34035015-77AB7827-D466-40A1-87BA-224375297D31Q34095808-17448B42-FA08-4D0E-98F1-B7D209CA7CD6Q34168198-203258E0-CF4A-46F2-9885-C0F84E58FBE1Q34174380-A4C48808-84F2-4B1E-972D-D3548EF09043Q34262449-11013573-35A7-45D8-8170-D9B74473E98CQ34993621-55A41A15-133D-4778-B075-5E3AC3A7BD8CQ35151555-62363649-537F-4A30-BA47-A6EEEA2BE0F7Q35670334-F1E745D0-AD53-48D5-9E6C-6CA7AA5D7788Q36680034-768DFE45-1163-485A-935A-B8E8F9A0651BQ36906183-B182DF76-3336-47B2-B7EB-11603C2897DBQ37158501-D7BD85DA-CB09-4BCA-A55E-E3AA84E06E9CQ37383022-66232E0F-577D-4236-A310-1614287562EEQ37729195-C167073E-0A1F-4E26-BFB2-D6E18046D9C1Q38053978-C8541665-BF04-4F00-B33B-05931A41F11FQ38732038-A88F5751-3C31-41D9-B757-438B751E5F53Q38789975-799297A9-2FF5-4BC4-AB2D-467AE9AF2F9BQ39061576-1C9CB622-1562-4119-BA75-FD291E79F18AQ39257066-53902536-19AD-4772-B6BD-187C0C283B47Q40139758-D915C0A5-E0D4-4F46-86AE-7D96C7E05661Q41701973-63608D05-6C31-4519-896B-486FF349084BQ42262252-88A4B521-955A-40B6-8588-4EE6576D36C1Q44220426-31D68347-C4FA-4CAE-8961-E6C5F544EE24Q44485496-9883EF7C-EFBE-419F-9091-2D9B2CFF103BQ44896541-26EBAB8F-9D88-4D6A-BA99-2A12517BC733Q47619222-30074226-CB07-49DB-9171-45C733537851Q47644799-55738E04-CA3D-42DE-B7DD-FDDE72F56FBFQ48027758-6F2FC8BE-BC79-44C0-9875-8E832B8289CBQ48112495-38D239F5-6A6E-4F85-B25B-60F2003A7325Q48171518-0BC3FD8A-5115-4077-B319-D40BAAEA954CQ48185503-3163BFF1-3F3F-41FE-868A-258A35765AD4Q48215849-73879E8B-CC70-43F2-AE04-B11321CFBEBCQ48565555-04E28576-AB67-4284-91DA-54535DEC1F6EQ53134306-A60F9BC8-2432-4041-B546-E9DCCFF73C5BQ55438987-1139C6F2-AF6F-4C0A-A742-AFFA96CC3201
P2860
International perspective on health-related quality-of-life research in cancer clinical trials: the European Organisation for Research and Treatment of Cancer experience
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
International perspective on h ...... Treatment of Cancer experience
@ast
International perspective on h ...... Treatment of Cancer experience
@en
International perspective on h ...... Treatment of Cancer experience
@nl
type
label
International perspective on h ...... Treatment of Cancer experience
@ast
International perspective on h ...... Treatment of Cancer experience
@en
International perspective on h ...... Treatment of Cancer experience
@nl
prefLabel
International perspective on h ...... Treatment of Cancer experience
@ast
International perspective on h ...... Treatment of Cancer experience
@en
International perspective on h ...... Treatment of Cancer experience
@nl
P356
P1476
International perspective on h ...... Treatment of Cancer experience
@en
P2093
Neil K Aaronson
P304
P356
10.1200/JCO.2007.11.3183
P407
P577
2007-11-10T00:00:00Z